Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data from 9222 Chronic Heart Failure Patients of the ESC-HFA-EORP Heart Failure Long-Term RegistryPatrick Rossignol, Mitja Lainščak, María G. Crespo‐Leiro et al.|European Journal of Heart Failure|2020Cited by 148
Role of biomarkers in monitoring antiblastic cardiotoxicityGiuseppina Novo, Maria Penco, Silvio Romano et al.|Journal of Cardiovascular Medicine|2016Cited by 24